View in EDS

Nivolumab plus relatlimab in advanced melanoma: RELATIVITY-047 4-year update.

Saved in:
Bibliographic Details
Title: Nivolumab plus relatlimab in advanced melanoma: RELATIVITY-047 4-year update.
Authors: Lipson EJ; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. Electronic address: evanlipson@jhmi.edu., Stephen Hodi F; Dana-Farber Cancer Institute, Boston, MA, USA., Tawbi H; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Schadendorf D; University of Essen and the German Cancer Consortium, Essen, Germany., Ascierto PA; Istituto Nazionale dei Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy., Matamala L; Instituto Oncológico Fundación Arturo López Pérez and Department of Oncology, Instituto Nacional del Cáncer, Santiago, Chile., Gutierrez EC; FAICIC Clinical Research, Veracruz, Mexico., Rutkowski P; Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Gogas HJ; National and Kapodistrian University of Athens, Athens, Greece., Lao CD; Michigan Medicine, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA., Menezes JJ; Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil., Dalle S; Hospices Civils de Lyon, Cancer Research Center of Lyon, Pierre-Bénite, France., Arance A; Hospital Clinic Barcelona and IDIBAPS, Barcelona, Spain., Gaudy-Marqueste C; Aix-Marseille University, APHM, CHU Timone, Marseille, France., Chen B; Bristol Myers Squibb, Princeton, NJ, USA., Jackson W; Bristol Myers Squibb, Princeton, NJ, USA., Mukherjee S; Bristol Myers Squibb, Princeton, NJ, USA., Dolfi S; Bristol Myers Squibb, Princeton, NJ, USA., Long GV; Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Jul 25; Vol. 225, pp. 115547. Date of Electronic Publication: 2025 Jun 03.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40513285
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Nivolumab plus relatlimab in advanced melanoma: RELATIVITY-047 4-year update.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lipson+EJ%22">Lipson EJ</searchLink>; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. Electronic address: evanlipson@jhmi.edu.<br /><searchLink fieldCode="AU" term="%22Stephen+Hodi+F%22">Stephen Hodi F</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Tawbi+H%22">Tawbi H</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Schadendorf+D%22">Schadendorf D</searchLink>; University of Essen and the German Cancer Consortium, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Ascierto+PA%22">Ascierto PA</searchLink>; Istituto Nazionale dei Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Matamala+L%22">Matamala L</searchLink>; Instituto Oncológico Fundación Arturo López Pérez and Department of Oncology, Instituto Nacional del Cáncer, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Gutierrez+EC%22">Gutierrez EC</searchLink>; FAICIC Clinical Research, Veracruz, Mexico.<br /><searchLink fieldCode="AU" term="%22Rutkowski+P%22">Rutkowski P</searchLink>; Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Gogas+HJ%22">Gogas HJ</searchLink>; National and Kapodistrian University of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Lao+CD%22">Lao CD</searchLink>; Michigan Medicine, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Menezes+JJ%22">Menezes JJ</searchLink>; Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil.<br /><searchLink fieldCode="AU" term="%22Dalle+S%22">Dalle S</searchLink>; Hospices Civils de Lyon, Cancer Research Center of Lyon, Pierre-Bénite, France.<br /><searchLink fieldCode="AU" term="%22Arance+A%22">Arance A</searchLink>; Hospital Clinic Barcelona and IDIBAPS, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Gaudy-Marqueste+C%22">Gaudy-Marqueste C</searchLink>; Aix-Marseille University, APHM, CHU Timone, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Chen+B%22">Chen B</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Jackson+W%22">Jackson W</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Mukherjee+S%22">Mukherjee S</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Dolfi+S%22">Dolfi S</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Long+GV%22">Long GV</searchLink>; Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2025 Jul 25; Vol. 225, pp. 115547. <i>Date of Electronic Publication: </i>2025 Jun 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Clinical Trial, Phase II; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40513285
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejca.2025.115547
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 115547
    Titles:
      – TitleFull: Nivolumab plus relatlimab in advanced melanoma: RELATIVITY-047 4-year update.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lipson EJ
      – PersonEntity:
          Name:
            NameFull: Stephen Hodi F
      – PersonEntity:
          Name:
            NameFull: Tawbi H
      – PersonEntity:
          Name:
            NameFull: Schadendorf D
      – PersonEntity:
          Name:
            NameFull: Ascierto PA
      – PersonEntity:
          Name:
            NameFull: Matamala L
      – PersonEntity:
          Name:
            NameFull: Gutierrez EC
      – PersonEntity:
          Name:
            NameFull: Rutkowski P
      – PersonEntity:
          Name:
            NameFull: Gogas HJ
      – PersonEntity:
          Name:
            NameFull: Lao CD
      – PersonEntity:
          Name:
            NameFull: Menezes JJ
      – PersonEntity:
          Name:
            NameFull: Dalle S
      – PersonEntity:
          Name:
            NameFull: Arance A
      – PersonEntity:
          Name:
            NameFull: Gaudy-Marqueste C
      – PersonEntity:
          Name:
            NameFull: Chen B
      – PersonEntity:
          Name:
            NameFull: Jackson W
      – PersonEntity:
          Name:
            NameFull: Mukherjee S
      – PersonEntity:
          Name:
            NameFull: Dolfi S
      – PersonEntity:
          Name:
            NameFull: Long GV
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 07
              Text: 2025 Jul 25
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1879-0852
          Numbering:
            – Type: volume
              Value: 225
          Titles:
            – TitleFull: European journal of cancer (Oxford, England : 1990)
              Type: main
ResultId 1